Trial site
Oklahoma Cancer Specialists and Research Institute
- 9running trials
- 6closed trials
The trials here
What the 15 trials at this site are about, from their registry records.
- Conditions
- Lung cancer5 trials
- Ovarian cancer3 trials
- Endometrial cancer2 trials
- Metastatic breast cancer2 trials
- Immune thrombocytopenia (ITP)1 trial
- Melanoma1 trial
- Multiple myeloma1 trial
- Prostate cancer1 trial
- Sarcoma1 trial
- Phase
- Phase 35 trials
- Phase 22 trials
- Phase 2/32 trials
- Phase 42 trials
- Phase 11 trial
- Status
- Active, not recruiting5 trials
- Completed5 trials
- Recruiting4 trials
- Withdrawn1 trial
- Lead sponsor
- Genentech, Inc.2 trials
- Novartis Pharmaceuticals2 trials
- AbbVie1 trial
- All4Cure1 trial
- Alliance Foundation Trials, LLC.1 trial
- and 8 more
Running trials
Recruiting
Recruiting
Recruiting
Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer
Active, not recruiting
Impact of a Health Technology Intervention on Patient Activation in Multiple Myeloma
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer2 recruiting
- Endometrial cancer1 recruiting
- Melanoma1 recruiting
- Ovarian cancer1 recruiting
- Sarcoma1 recruiting
Closed trials
Withdrawn
Completed
Completed
Completed
A Study of Tepotinib Plus Osimertinib in Osimertinib Relapsed MET Amplified NSCLC (INSIGHT 2)
Completed
A Study of Androgen Annihilation in High-Risk Biochemically Relapsed Prostate Cancer
Completed
Site data: ClinicalTrials.govUpdated 13 Nov 2026